Knoll Capital Management, LP
13F Reported Value
ⓘ$180.2M
Holdings
37
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
Knoll Capital Management, LP disclosed 37 positions worth $180.2M in its Form 13F-HR for Q1 2026, led by $BHVN (Biohaven Ltd.) at 10.9% of the equity portfolio, followed by $PHYS and $RGLD. During the quarter the fund opened 8 new positions and exited 4 — including a new stake in $PHYS and a full exit from $AVDL. The portfolio is most concentrated in Healthcare (37.4% of disclosed assets). All figures are sourced directly from Knoll Capital Management, LP’s Form 13F-HR filing with the SEC under CIK 1325083.
AI Fund Analysis
DiversifyingSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
- —
Quality
$19.7M2,328,602 sh - —
Quality
$13.7M387,055 sh - 79.4#54
Quality
$13.4M52,750 sh - —
Quality
$10.8M1,250,000 sh - —
Quality
$10.7M52,750 sh - —
Quality
$9.8M320,000 sh - —
Quality
$9.3M5,475,516 sh - —
Quality
$9.0M317,003 sh - —
Quality
$7.9M32,000 sh - 61.9
Quality
$7.2M245,000 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 Biohaven Ltd.$BHVN | — | $19.7M | 2,328,602 |
 Sprott Physical Gold Trust$PHYS | — | $13.7M | 387,055 |
 ROYAL GOLD INC$RGLD | 79.4#54 | $13.4M | 52,750 |
 MeiraGTx Holdings plc$MGTX | — | $10.8M | 1,250,000 |
 AGNICO EAGLE MINES LTD$AEM | — | $10.7M | 52,750 |
 KINROSS GOLD CORP$KGC | — | $9.8M | 320,000 |
 Aldeyra Therapeutics, Inc.$ALDX | — | $9.3M | 5,475,516 |
 SEABRIDGE GOLD INC$SA | — | $9.0M | 317,003 |
 FRANCO NEVADA Corp$FNV | — | $7.9M | 32,000 |
 SSR MINING INC.$SSRM | 61.9 | $7.2M | 245,000 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Knoll Capital Management, LP's 37 positions.
Showing top 10 of 37 holdings.
Sector Allocation
Healthcare
$67.4M
Materials
$62.6M
Financials
$44.4M
Technology
$2.5M
Other
$1.7M
Consumer Staples
$1.7M
Full Holdings — Knoll Capital Management, LP (Q1 2026)
All 37 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $BHVN | Biohaven Ltd. | $19.7M | 10.9% | +0% | — |
| 2 | $PHYS | Sprott Physical Gold Trust | $13.7M | 7.6% | NEW | — |
| 3 | $RGLD | ROYAL GOLD INC | $13.4M | 7.5% | +0% | 79.4 |
| 4 | $MGTX | MeiraGTx Holdings plc | $10.8M | 6.0% | +0% | — |
| 5 | $AEM | AGNICO EAGLE MINES LTD | $10.7M | 5.9% | +0% | — |
| 6 | $KGC | KINROSS GOLD CORP | $9.8M | 5.4% | -22% | — |
| 7 | $ALDX | Aldeyra Therapeutics, Inc. | $9.3M | 5.1% | +0% | — |
| 8 | $SA | SEABRIDGE GOLD INC | $9.0M | 5.0% | +0% | — |
| 9 | $FNV | FRANCO NEVADA Corp | $7.9M | 4.4% | +28% | — |
| 10 | $SSRM | SSR MINING INC. | $7.2M | 4.0% | +0% | 61.9 |
| 11 |  $ELTX | Elicio Therapeutics, Inc. | $6.7M | 3.7% | +0% | — |
| 12 |  $ENTX | Entera Bio Ltd. | $6.5M | 3.6% | +0% | — |
| 13 |  $NUVB | Nuvation Bio Inc. | $6.4M | 3.6% | +0% | 29.5 |
| 14 |  $CGAU | Centerra Gold Inc. | $6.4M | 3.5% | -28% | — |
| 15 |  $PAAS | PAN AMERICAN SILVER CORP | $5.5M | 3.0% | +0% | — |
| 16 |  $PSLV | Sprott Physical Silver Trust | $5.4M | 3.0% | NEW | — |
| 17 |  $OCUL | OCULAR THERAPEUTIX, INC | $5.1M | 2.8% | +0% | 12.8 |
| 18 |  $TFPM | Triple Flag Precious Metals Corp. | $4.0M | 2.2% | +96% | — |
| 19 |  $GROY | Gold Royalty Corp. | $3.6M | 2.0% | NEW | — |
| 20 |  $AGI | ALAMOS GOLD INC | $2.2M | 1.2% | +0% | — |
| 21 |  $ABEO | ABEONA THERAPEUTICS INC. | $2.2M | 1.2% | +106% | 44.3 |
| 22 |  $NEWP | NEW PACIFIC METALS CORP | $2.0M | 1.1% | +0% | — |
| 23 |  $CDE | Coeur Mining, Inc. | $1.8M | 1.0% | +0% | 78.1 |
| 24 | — | iSHares US Aerospace & Defense | $1.7M | 0.9% | +0% | — |
| 25 |  $PM | Philip Morris International Inc. | $1.7M | 0.9% | +0% | 80.5 |
| 26 |  $WPM | Wheaton Precious Metals Corp. | $1.6M | 0.9% | +0% | — |
| 27 |  $NOC | NORTHROP GRUMMAN CORP /DE/ | $1.5M | 0.8% | +0% | 60.5 |
| 28 |  $BAH | Booz Allen Hamilton Holding Corp | $1.0M | 0.6% | +0% | 65.5 |
| 29 |  $ELE | Elemental Royalty Corp | $943,000 | 0.5% | NEW | — |
| 30 |  $VMET | Versamet Royalties Corp | $633,565 | 0.3% | NEW | — |
| 31 |  $DC | Dakota Gold Corp. | $620,751 | 0.3% | +0% | — |
| 32 |  $AMRZ | Amrize Ltd | $513,983 | 0.3% | NEW | — |
| 33 |  $ALT | Altimmune, Inc. | $492,800 | 0.3% | -86% | 7.3 |
| 34 |  $CRDL | Cardiol Therapeutics Inc. | $135,000 | 0.1% | +0% | — |
| 35 |  $PHAR | Pharming Group N.V. | $67,508 | 0.0% | NEW | — |
| 36 | — | Orgenesis, Inc. | $30,373 | 0.0% | +0% | — |
| 37 |  $OR | OR Royalties Inc. | $8,555 | 0.0% | NEW | — |
New Positions (8)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Knoll Capital Management, LP including:
Track Knoll Capital Management, LP's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Knoll Capital Management, LP and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Knoll Capital Management, LP
13F Pro is an AI hedge fund tracker and stock research platform. For Knoll Capital Management, LP (SEC CIK: 1325083), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Knoll Capital Management, LP's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.